Global Gastrointestinal Stromal Tumor Gist Drug Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Gastrointestinal Stromal Tumor Gist Drug market size was estimated at USD 1456.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal Stromal Tumor Gist Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal Stromal Tumor Gist Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal Stromal Tumor Gist Drug market.
Global Gastrointestinal Stromal Tumor Gist Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Market Segmentation (by Type)
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Gist Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumor Gist Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gastrointestinal Stromal Tumor Gist Drug market size was estimated at USD 1456.3 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal Stromal Tumor Gist Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal Stromal Tumor Gist Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal Stromal Tumor Gist Drug market.
Global Gastrointestinal Stromal Tumor Gist Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Market Segmentation (by Type)
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Stromal Tumor Gist Drug Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor Gist Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal Stromal Tumor Gist Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor Gist Drug
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumor Gist Drug Segment by Type
1.2.2 Gastrointestinal Stromal Tumor Gist Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gastrointestinal Stromal Tumor Gist Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Stromal Tumor Gist Drug Product Life Cycle
3.3 Global Gastrointestinal Stromal Tumor Gist Drug Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Stromal Tumor Gist Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Stromal Tumor Gist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Stromal Tumor Gist Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal Stromal Tumor Gist Drug Market Competitive Situation and Trends
3.8.1 Gastrointestinal Stromal Tumor Gist Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor Gist Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR GIST DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumor Gist Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Stromal Tumor Gist Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumor Gist Drug Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Type (2020-2025)
6.4 Global Gastrointestinal Stromal Tumor Gist Drug Price by Type (2020-2025)
7 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal Stromal Tumor Gist Drug Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET SALES BY REGION
8.1 Global Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region
8.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.2.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.2.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.3 North America
8.3.1 North America Gastrointestinal Stromal Tumor Gist Drug Sales by Country
8.3.2 North America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal Stromal Tumor Gist Drug Sales by Country
8.4.2 Europe Gastrointestinal Stromal Tumor Gist Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.5.2 Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal Stromal Tumor Gist Drug Sales by Country
8.6.2 South America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.7.2 Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal Stromal Tumor Gist Drug by Region(2020-2025)
9.2 Global Gastrointestinal Stromal Tumor Gist Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal Stromal Tumor Gist Drug Production
9.4.1 North America Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal Stromal Tumor Gist Drug Production
9.5.1 Europe Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal Stromal Tumor Gist Drug Production (2020-2025)
9.6.1 Japan Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal Stromal Tumor Gist Drug Production (2020-2025)
9.7.1 China Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ariad Pharmaceuticals, Inc.
10.1.1 Ariad Pharmaceuticals, Inc. Basic Information
10.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.1.4 Ariad Pharmaceuticals, Inc. Business Overview
10.1.5 Ariad Pharmaceuticals, Inc. SWOT Analysis
10.1.6 Ariad Pharmaceuticals, Inc. Recent Developments
10.2 Arog Pharmaceuticals, Inc.
10.2.1 Arog Pharmaceuticals, Inc. Basic Information
10.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.2.4 Arog Pharmaceuticals, Inc. Business Overview
10.2.5 Arog Pharmaceuticals, Inc. SWOT Analysis
10.2.6 Arog Pharmaceuticals, Inc. Recent Developments
10.3 Array BioPharma Inc.
10.3.1 Array BioPharma Inc. Basic Information
10.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.3.4 Array BioPharma Inc. Business Overview
10.3.5 Array BioPharma Inc. SWOT Analysis
10.3.6 Array BioPharma Inc. Recent Developments
10.4 Astex Pharmaceuticals, Inc.
10.4.1 Astex Pharmaceuticals, Inc. Basic Information
10.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.4.4 Astex Pharmaceuticals, Inc. Business Overview
10.4.5 Astex Pharmaceuticals, Inc. Recent Developments
10.5 Blueprint Medicines Corporation
10.5.1 Blueprint Medicines Corporation Basic Information
10.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.5.4 Blueprint Medicines Corporation Business Overview
10.5.5 Blueprint Medicines Corporation Recent Developments
10.6 Boston Biomedical, Inc.
10.6.1 Boston Biomedical, Inc. Basic Information
10.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.6.4 Boston Biomedical, Inc. Business Overview
10.6.5 Boston Biomedical, Inc. Recent Developments
10.7 Calithera Biosciences, Inc.
10.7.1 Calithera Biosciences, Inc. Basic Information
10.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.7.4 Calithera Biosciences, Inc. Business Overview
10.7.5 Calithera Biosciences, Inc. Recent Developments
10.8 Chipscreen Biosciences Ltd
10.8.1 Chipscreen Biosciences Ltd Basic Information
10.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.8.4 Chipscreen Biosciences Ltd Business Overview
10.8.5 Chipscreen Biosciences Ltd Recent Developments
10.9 Deciphera Pharmaceuticals, LLC
10.9.1 Deciphera Pharmaceuticals, LLC Basic Information
10.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.9.4 Deciphera Pharmaceuticals, LLC Business Overview
10.9.5 Deciphera Pharmaceuticals, LLC Recent Developments
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 F. Hoffmann-La Roche Ltd. Basic Information
10.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.10.4 F. Hoffmann-La Roche Ltd. Business Overview
10.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.11 Horizon Pharma Plc
10.11.1 Horizon Pharma Plc Basic Information
10.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.11.4 Horizon Pharma Plc Business Overview
10.11.5 Horizon Pharma Plc Recent Developments
10.12 Immunicum AB
10.12.1 Immunicum AB Basic Information
10.12.2 Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.12.3 Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.12.4 Immunicum AB Business Overview
10.12.5 Immunicum AB Recent Developments
10.13 Jiangsu Hengrui Medicine Co., Ltd.
10.13.1 Jiangsu Hengrui Medicine Co., Ltd. Basic Information
10.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.13.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
10.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
10.14 Kolltan Pharmaceuticals, Inc.
10.14.1 Kolltan Pharmaceuticals, Inc. Basic Information
10.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.14.4 Kolltan Pharmaceuticals, Inc. Business Overview
10.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments
10.15 Natco Pharma Limited
10.15.1 Natco Pharma Limited Basic Information
10.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.15.4 Natco Pharma Limited Business Overview
10.15.5 Natco Pharma Limited Recent Developments
10.16 Nerviano Medical Sciences S.r.l.
10.16.1 Nerviano Medical Sciences S.r.l. Basic Information
10.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.16.4 Nerviano Medical Sciences S.r.l. Business Overview
10.16.5 Nerviano Medical Sciences S.r.l. Recent Developments
10.17 Novartis AG
10.17.1 Novartis AG Basic Information
10.17.2 Novartis AG Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.17.3 Novartis AG Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.17.4 Novartis AG Business Overview
10.17.5 Novartis AG Recent Developments
10.18 Omeros Corporation
10.18.1 Omeros Corporation Basic Information
10.18.2 Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.18.3 Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.18.4 Omeros Corporation Business Overview
10.18.5 Omeros Corporation Recent Developments
11 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET FORECAST BY REGION
11.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast
11.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Region
11.2.4 South America Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumor Gist Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor Gist Drug by Type (2026-2035)
12.1.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor Gist Drug by Type (2026-2035)
12.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor Gist Drug
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumor Gist Drug Segment by Type
1.2.2 Gastrointestinal Stromal Tumor Gist Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gastrointestinal Stromal Tumor Gist Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal Stromal Tumor Gist Drug Product Life Cycle
3.3 Global Gastrointestinal Stromal Tumor Gist Drug Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal Stromal Tumor Gist Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal Stromal Tumor Gist Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal Stromal Tumor Gist Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal Stromal Tumor Gist Drug Market Competitive Situation and Trends
3.8.1 Gastrointestinal Stromal Tumor Gist Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor Gist Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR GIST DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumor Gist Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal Stromal Tumor Gist Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal Stromal Tumor Gist Drug Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Type (2020-2025)
6.4 Global Gastrointestinal Stromal Tumor Gist Drug Price by Type (2020-2025)
7 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal Stromal Tumor Gist Drug Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET SALES BY REGION
8.1 Global Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region
8.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.2.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.2.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.3 North America
8.3.1 North America Gastrointestinal Stromal Tumor Gist Drug Sales by Country
8.3.2 North America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal Stromal Tumor Gist Drug Sales by Country
8.4.2 Europe Gastrointestinal Stromal Tumor Gist Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.5.2 Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal Stromal Tumor Gist Drug Sales by Country
8.6.2 South America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales by Region
8.7.2 Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal Stromal Tumor Gist Drug by Region(2020-2025)
9.2 Global Gastrointestinal Stromal Tumor Gist Drug Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal Stromal Tumor Gist Drug Production
9.4.1 North America Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal Stromal Tumor Gist Drug Production
9.5.1 Europe Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal Stromal Tumor Gist Drug Production (2020-2025)
9.6.1 Japan Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal Stromal Tumor Gist Drug Production (2020-2025)
9.7.1 China Gastrointestinal Stromal Tumor Gist Drug Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal Stromal Tumor Gist Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ariad Pharmaceuticals, Inc.
10.1.1 Ariad Pharmaceuticals, Inc. Basic Information
10.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.1.4 Ariad Pharmaceuticals, Inc. Business Overview
10.1.5 Ariad Pharmaceuticals, Inc. SWOT Analysis
10.1.6 Ariad Pharmaceuticals, Inc. Recent Developments
10.2 Arog Pharmaceuticals, Inc.
10.2.1 Arog Pharmaceuticals, Inc. Basic Information
10.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.2.4 Arog Pharmaceuticals, Inc. Business Overview
10.2.5 Arog Pharmaceuticals, Inc. SWOT Analysis
10.2.6 Arog Pharmaceuticals, Inc. Recent Developments
10.3 Array BioPharma Inc.
10.3.1 Array BioPharma Inc. Basic Information
10.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.3.4 Array BioPharma Inc. Business Overview
10.3.5 Array BioPharma Inc. SWOT Analysis
10.3.6 Array BioPharma Inc. Recent Developments
10.4 Astex Pharmaceuticals, Inc.
10.4.1 Astex Pharmaceuticals, Inc. Basic Information
10.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.4.4 Astex Pharmaceuticals, Inc. Business Overview
10.4.5 Astex Pharmaceuticals, Inc. Recent Developments
10.5 Blueprint Medicines Corporation
10.5.1 Blueprint Medicines Corporation Basic Information
10.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.5.4 Blueprint Medicines Corporation Business Overview
10.5.5 Blueprint Medicines Corporation Recent Developments
10.6 Boston Biomedical, Inc.
10.6.1 Boston Biomedical, Inc. Basic Information
10.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.6.4 Boston Biomedical, Inc. Business Overview
10.6.5 Boston Biomedical, Inc. Recent Developments
10.7 Calithera Biosciences, Inc.
10.7.1 Calithera Biosciences, Inc. Basic Information
10.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.7.4 Calithera Biosciences, Inc. Business Overview
10.7.5 Calithera Biosciences, Inc. Recent Developments
10.8 Chipscreen Biosciences Ltd
10.8.1 Chipscreen Biosciences Ltd Basic Information
10.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.8.4 Chipscreen Biosciences Ltd Business Overview
10.8.5 Chipscreen Biosciences Ltd Recent Developments
10.9 Deciphera Pharmaceuticals, LLC
10.9.1 Deciphera Pharmaceuticals, LLC Basic Information
10.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.9.4 Deciphera Pharmaceuticals, LLC Business Overview
10.9.5 Deciphera Pharmaceuticals, LLC Recent Developments
10.10 F. Hoffmann-La Roche Ltd.
10.10.1 F. Hoffmann-La Roche Ltd. Basic Information
10.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.10.4 F. Hoffmann-La Roche Ltd. Business Overview
10.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.11 Horizon Pharma Plc
10.11.1 Horizon Pharma Plc Basic Information
10.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.11.4 Horizon Pharma Plc Business Overview
10.11.5 Horizon Pharma Plc Recent Developments
10.12 Immunicum AB
10.12.1 Immunicum AB Basic Information
10.12.2 Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.12.3 Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.12.4 Immunicum AB Business Overview
10.12.5 Immunicum AB Recent Developments
10.13 Jiangsu Hengrui Medicine Co., Ltd.
10.13.1 Jiangsu Hengrui Medicine Co., Ltd. Basic Information
10.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.13.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
10.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
10.14 Kolltan Pharmaceuticals, Inc.
10.14.1 Kolltan Pharmaceuticals, Inc. Basic Information
10.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.14.4 Kolltan Pharmaceuticals, Inc. Business Overview
10.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments
10.15 Natco Pharma Limited
10.15.1 Natco Pharma Limited Basic Information
10.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.15.4 Natco Pharma Limited Business Overview
10.15.5 Natco Pharma Limited Recent Developments
10.16 Nerviano Medical Sciences S.r.l.
10.16.1 Nerviano Medical Sciences S.r.l. Basic Information
10.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.16.4 Nerviano Medical Sciences S.r.l. Business Overview
10.16.5 Nerviano Medical Sciences S.r.l. Recent Developments
10.17 Novartis AG
10.17.1 Novartis AG Basic Information
10.17.2 Novartis AG Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.17.3 Novartis AG Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.17.4 Novartis AG Business Overview
10.17.5 Novartis AG Recent Developments
10.18 Omeros Corporation
10.18.1 Omeros Corporation Basic Information
10.18.2 Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
10.18.3 Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Product Market Performance
10.18.4 Omeros Corporation Business Overview
10.18.5 Omeros Corporation Recent Developments
11 GASTROINTESTINAL STROMAL TUMOR GIST DRUG MARKET FORECAST BY REGION
11.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast
11.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Region
11.2.4 South America Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal Stromal Tumor Gist Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gastrointestinal Stromal Tumor Gist Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor Gist Drug by Type (2026-2035)
12.1.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor Gist Drug by Type (2026-2035)
12.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Forecast by Application (2026-2035)
12.2.1 Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Type (M USD)
Table 4. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Application
Table 5. Gastrointestinal Stromal Tumor Gist Drug Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Stromal Tumor Gist Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal Stromal Tumor Gist Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Gist Drug as of 2025)
Table 11. Global Market Gastrointestinal Stromal Tumor Gist Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gastrointestinal Stromal Tumor Gist Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor Gist Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gastrointestinal Stromal Tumor Gist Drug Sales by Type (K MT)
Table 27. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Type (M USD)
Table 28. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Type (2020-2025)
Table 32. Global Gastrointestinal Stromal Tumor Gist Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) by Application
Table 34. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Application
Table 35. Global Gastrointestinal Stromal Tumor Gist Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application (2020-2025)
Table 39. Global Gastrointestinal Stromal Tumor Gist Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gastrointestinal Stromal Tumor Gist Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025)
Table 44. North America Gastrointestinal Stromal Tumor Gist Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gastrointestinal Stromal Tumor Gist Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gastrointestinal Stromal Tumor Gist Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gastrointestinal Stromal Tumor Gist Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gastrointestinal Stromal Tumor Gist Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gastrointestinal Stromal Tumor Gist Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Ariad Pharmaceuticals, Inc. Basic Information
Table 63. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 64. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Ariad Pharmaceuticals, Inc. Business Overview
Table 66. Ariad Pharmaceuticals, Inc. SWOT Analysis
Table 67. Ariad Pharmaceuticals, Inc. Recent Developments
Table 68. Arog Pharmaceuticals, Inc. Basic Information
Table 69. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 70. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Arog Pharmaceuticals, Inc. Business Overview
Table 72. Arog Pharmaceuticals, Inc. SWOT Analysis
Table 73. Arog Pharmaceuticals, Inc. Recent Developments
Table 74. Array BioPharma Inc. Basic Information
Table 75. Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 76. Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Array BioPharma Inc. Business Overview
Table 78. Array BioPharma Inc. SWOT Analysis
Table 79. Array BioPharma Inc. Recent Developments
Table 80. Astex Pharmaceuticals, Inc. Basic Information
Table 81. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 82. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Astex Pharmaceuticals, Inc. Business Overview
Table 84. Astex Pharmaceuticals, Inc. Recent Developments
Table 85. Blueprint Medicines Corporation Basic Information
Table 86. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 87. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Blueprint Medicines Corporation Business Overview
Table 89. Blueprint Medicines Corporation Recent Developments
Table 90. Boston Biomedical, Inc. Basic Information
Table 91. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 92. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Boston Biomedical, Inc. Business Overview
Table 94. Boston Biomedical, Inc. Recent Developments
Table 95. Calithera Biosciences, Inc. Basic Information
Table 96. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 97. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Calithera Biosciences, Inc. Business Overview
Table 99. Calithera Biosciences, Inc. Recent Developments
Table 100. Chipscreen Biosciences Ltd Basic Information
Table 101. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 102. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Chipscreen Biosciences Ltd Business Overview
Table 104. Chipscreen Biosciences Ltd Recent Developments
Table 105. Deciphera Pharmaceuticals, LLC Basic Information
Table 106. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 107. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Deciphera Pharmaceuticals, LLC Business Overview
Table 109. Deciphera Pharmaceuticals, LLC Recent Developments
Table 110. F. Hoffmann-La Roche Ltd. Basic Information
Table 111. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 112. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. F. Hoffmann-La Roche Ltd. Business Overview
Table 114. F. Hoffmann-La Roche Ltd. Recent Developments
Table 115. Horizon Pharma Plc Basic Information
Table 116. Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 117. Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Horizon Pharma Plc Business Overview
Table 119. Horizon Pharma Plc Recent Developments
Table 120. Immunicum AB Basic Information
Table 121. Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 122. Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Immunicum AB Business Overview
Table 124. Immunicum AB Recent Developments
Table 125. Jiangsu Hengrui Medicine Co., Ltd. Basic Information
Table 126. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 127. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 129. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 130. Kolltan Pharmaceuticals, Inc. Basic Information
Table 131. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 132. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Kolltan Pharmaceuticals, Inc. Business Overview
Table 134. Kolltan Pharmaceuticals, Inc. Recent Developments
Table 135. Natco Pharma Limited Basic Information
Table 136. Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 137. Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Natco Pharma Limited Business Overview
Table 139. Natco Pharma Limited Recent Developments
Table 140. Nerviano Medical Sciences S.r.l. Basic Information
Table 141. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 142. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Nerviano Medical Sciences S.r.l. Business Overview
Table 144. Nerviano Medical Sciences S.r.l. Recent Developments
Table 145. Novartis AG Basic Information
Table 146. Novartis AG Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 147. Novartis AG Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Novartis AG Business Overview
Table 149. Novartis AG Recent Developments
Table 150. Omeros Corporation Basic Information
Table 151. Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 152. Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Omeros Corporation Business Overview
Table 154. Omeros Corporation Recent Developments
Table 155. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Gastrointestinal Stromal Tumor Gist Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Type (M USD)
Table 4. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Application
Table 5. Gastrointestinal Stromal Tumor Gist Drug Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal Stromal Tumor Gist Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal Stromal Tumor Gist Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor Gist Drug as of 2025)
Table 11. Global Market Gastrointestinal Stromal Tumor Gist Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gastrointestinal Stromal Tumor Gist Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor Gist Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gastrointestinal Stromal Tumor Gist Drug Sales by Type (K MT)
Table 27. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Type (M USD)
Table 28. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Type (2020-2025)
Table 30. Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Type (2020-2025)
Table 32. Global Gastrointestinal Stromal Tumor Gist Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) by Application
Table 34. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Application
Table 35. Global Gastrointestinal Stromal Tumor Gist Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Application (2020-2025)
Table 37. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application (2020-2025)
Table 39. Global Gastrointestinal Stromal Tumor Gist Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Gastrointestinal Stromal Tumor Gist Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region (2020-2025)
Table 42. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025)
Table 44. North America Gastrointestinal Stromal Tumor Gist Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gastrointestinal Stromal Tumor Gist Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gastrointestinal Stromal Tumor Gist Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gastrointestinal Stromal Tumor Gist Drug Production (K MT) by Region(2020-2025)
Table 55. Global Gastrointestinal Stromal Tumor Gist Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gastrointestinal Stromal Tumor Gist Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gastrointestinal Stromal Tumor Gist Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Ariad Pharmaceuticals, Inc. Basic Information
Table 63. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 64. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Ariad Pharmaceuticals, Inc. Business Overview
Table 66. Ariad Pharmaceuticals, Inc. SWOT Analysis
Table 67. Ariad Pharmaceuticals, Inc. Recent Developments
Table 68. Arog Pharmaceuticals, Inc. Basic Information
Table 69. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 70. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Arog Pharmaceuticals, Inc. Business Overview
Table 72. Arog Pharmaceuticals, Inc. SWOT Analysis
Table 73. Arog Pharmaceuticals, Inc. Recent Developments
Table 74. Array BioPharma Inc. Basic Information
Table 75. Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 76. Array BioPharma Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Array BioPharma Inc. Business Overview
Table 78. Array BioPharma Inc. SWOT Analysis
Table 79. Array BioPharma Inc. Recent Developments
Table 80. Astex Pharmaceuticals, Inc. Basic Information
Table 81. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 82. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Astex Pharmaceuticals, Inc. Business Overview
Table 84. Astex Pharmaceuticals, Inc. Recent Developments
Table 85. Blueprint Medicines Corporation Basic Information
Table 86. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 87. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Blueprint Medicines Corporation Business Overview
Table 89. Blueprint Medicines Corporation Recent Developments
Table 90. Boston Biomedical, Inc. Basic Information
Table 91. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 92. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Boston Biomedical, Inc. Business Overview
Table 94. Boston Biomedical, Inc. Recent Developments
Table 95. Calithera Biosciences, Inc. Basic Information
Table 96. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 97. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Calithera Biosciences, Inc. Business Overview
Table 99. Calithera Biosciences, Inc. Recent Developments
Table 100. Chipscreen Biosciences Ltd Basic Information
Table 101. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 102. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Chipscreen Biosciences Ltd Business Overview
Table 104. Chipscreen Biosciences Ltd Recent Developments
Table 105. Deciphera Pharmaceuticals, LLC Basic Information
Table 106. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 107. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Deciphera Pharmaceuticals, LLC Business Overview
Table 109. Deciphera Pharmaceuticals, LLC Recent Developments
Table 110. F. Hoffmann-La Roche Ltd. Basic Information
Table 111. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 112. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. F. Hoffmann-La Roche Ltd. Business Overview
Table 114. F. Hoffmann-La Roche Ltd. Recent Developments
Table 115. Horizon Pharma Plc Basic Information
Table 116. Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 117. Horizon Pharma Plc Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Horizon Pharma Plc Business Overview
Table 119. Horizon Pharma Plc Recent Developments
Table 120. Immunicum AB Basic Information
Table 121. Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 122. Immunicum AB Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Immunicum AB Business Overview
Table 124. Immunicum AB Recent Developments
Table 125. Jiangsu Hengrui Medicine Co., Ltd. Basic Information
Table 126. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 127. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 129. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 130. Kolltan Pharmaceuticals, Inc. Basic Information
Table 131. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 132. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Kolltan Pharmaceuticals, Inc. Business Overview
Table 134. Kolltan Pharmaceuticals, Inc. Recent Developments
Table 135. Natco Pharma Limited Basic Information
Table 136. Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 137. Natco Pharma Limited Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Natco Pharma Limited Business Overview
Table 139. Natco Pharma Limited Recent Developments
Table 140. Nerviano Medical Sciences S.r.l. Basic Information
Table 141. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 142. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Nerviano Medical Sciences S.r.l. Business Overview
Table 144. Nerviano Medical Sciences S.r.l. Recent Developments
Table 145. Novartis AG Basic Information
Table 146. Novartis AG Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 147. Novartis AG Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Novartis AG Business Overview
Table 149. Novartis AG Recent Developments
Table 150. Omeros Corporation Basic Information
Table 151. Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Product Overview
Table 152. Omeros Corporation Gastrointestinal Stromal Tumor Gist Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Omeros Corporation Business Overview
Table 154. Omeros Corporation Recent Developments
Table 155. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 156. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 157. North America Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 158. North America Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 159. Europe Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 160. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 161. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 162. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 163. South America Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 164. South America Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 165. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Country (2026-2035) & (Units)
Table 166. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 167. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 168. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 169. Global Gastrointestinal Stromal Tumor Gist Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 170. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) Forecast by Application (2026-2035)
Table 171. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Stromal Tumor Gist Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD), 2025-2035
Figure 5. Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Stromal Tumor Gist Drug Product Life Cycle
Figure 13. Gastrointestinal Stromal Tumor Gist Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gastrointestinal Stromal Tumor Gist Drug Revenue Share by Manufacturers in 2025
Figure 15. Gastrointestinal Stromal Tumor Gist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gastrointestinal Stromal Tumor Gist Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor Gist Drug Revenue in 2025
Figure 18. Industry Chain Map of Gastrointestinal Stromal Tumor Gist Drug
Figure 19. Global Gastrointestinal Stromal Tumor Gist Drug Market PEST Analysis
Figure 20. Global Gastrointestinal Stromal Tumor Gist Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type in 2025
Figure 29. Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type (2020-2025)
Figure 30. Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application
Figure 33. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Application in 2025
Figure 35. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application in 2025
Figure 37. Global Gastrointestinal Stromal Tumor Gist Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025)
Figure 40. North America Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country in 2024
Figure 45. U.S. Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal Stromal Tumor Gist Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal Stromal Tumor Gist Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size by Country in 2024
Figure 55. Germany Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size by Region in 2024
Figure 68. China Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (K MT)
Figure 79. South America Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country in 2024
Figure 82. Brazil Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal Stromal Tumor Gist Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gastrointestinal Stromal Tumor Gist Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gastrointestinal Stromal Tumor Gist Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gastrointestinal Stromal Tumor Gist Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD), 2025-2035
Figure 5. Global Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) (2020-2035)
Figure 6. Global Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor Gist Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal Stromal Tumor Gist Drug Product Life Cycle
Figure 13. Gastrointestinal Stromal Tumor Gist Drug Sales Share by Manufacturers in 2025
Figure 14. Global Gastrointestinal Stromal Tumor Gist Drug Revenue Share by Manufacturers in 2025
Figure 15. Gastrointestinal Stromal Tumor Gist Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gastrointestinal Stromal Tumor Gist Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor Gist Drug Revenue in 2025
Figure 18. Industry Chain Map of Gastrointestinal Stromal Tumor Gist Drug
Figure 19. Global Gastrointestinal Stromal Tumor Gist Drug Market PEST Analysis
Figure 20. Global Gastrointestinal Stromal Tumor Gist Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type in 2025
Figure 29. Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type (2020-2025)
Figure 30. Market Share of Gastrointestinal Stromal Tumor Gist Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application
Figure 33. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Application in 2025
Figure 35. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal Stromal Tumor Gist Drug Market Share by Application in 2025
Figure 37. Global Gastrointestinal Stromal Tumor Gist Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal Stromal Tumor Gist Drug Market Size by Region (2020-2025)
Figure 40. North America Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country in 2024
Figure 45. U.S. Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal Stromal Tumor Gist Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal Stromal Tumor Gist Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal Stromal Tumor Gist Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal Stromal Tumor Gist Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal Stromal Tumor Gist Drug Market Size by Country in 2024
Figure 55. Germany Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal Stromal Tumor Gist Drug Market Size by Region in 2024
Figure 68. China Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (K MT)
Figure 79. South America Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal Stromal Tumor Gist Drug Market Size by Country in 2024
Figure 82. Brazil Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal Stromal Tumor Gist Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal Stromal Tumor Gist Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gastrointestinal Stromal Tumor Gist Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal Stromal Tumor Gist Drug Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal Stromal Tumor Gist Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gastrointestinal Stromal Tumor Gist Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gastrointestinal Stromal Tumor Gist Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gastrointestinal Stromal Tumor Gist Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Gastrointestinal Stromal Tumor Gist Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Gastrointestinal Stromal Tumor Gist Drug Market Share Forecast by Application (2026-2035)
